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Abstract
Background: Depression is common among diabetic subjects. We conducted the present study
to estimate the prevalence of depression in subjects with type 2 diabetes (T2D) in Greece.
Methods: The study sample consisted of 320 T2D subjects without overt macrovascular disease
attending the diabetes outpatient clinic of our hospital, from June 2007 to December 2007.
Depressive symptoms were measured using the 21-item Beck Depression Inventory, modified for
use in diabetic subjects.
Results: Of the study subjects 107 (33.4%) reported elevated depressive symptoms. More women
than men with diabetes reported symptoms of depression (48.4% vs. 12.7%, P < 0.001). In the
female study group, depressive symptoms were correlated with HbA1c (P = 0.04), and duration of
diabetes (P = 0.004). In the male study group, univariate linear regression analysis showed no
significant relationships between depressive symptoms and the testing variables.
Conclusion: The prevalence of depression in Greek T2D subjects is high. Diabetic female subjects
showed increased levels of depressive symptoms compared with male subjects. Independent risk
factors of depressive symptoms in diabetic female subjects were diabetes duration and glycemic
control.
Background
Depression is common among people with diabetes [1],
especially among those with diabetic complications [2].
Depression has been associated with poor adherence to
medication [3], poor glycemic control [4], as well as with
the development of diabetic complications [5] and
increased mortality [6]. Several studies focusing on the
prevalence of depression in people with diabetes have
been done, showing different depression rates [7,8].
The available data regarding the prevalence of depression
among subjects with type 2 diabetes (T2D) in Greece are
limited. We, therefore, conducted the present study to
evaluate the prevalence of depressive symptoms as well as
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gender differences in subjects with T2D. In addition, the
relationship between depressive symptoms and glycemic
control was examined.
Methods
Population
The study sample consisted of 320 subjects (age 35–70
years) with T2D attending the diabetes outpatient clinic of
our hospital, from June 2007 to December 2007. T2D was
diagnosed according to the American Diabetes Associa-
tion criteria [9]. Subjects with clinically apparent macrov-
ascular disease (coronary, peripheral and carotid artery
disease or stroke) and on insulin treatment were excluded
since it has been shown that they have high prevalence of
depressive symptoms [4,5]. The study protocol was
approved by the Scientific and Ethical Committee of the
General Hospital of Nikaia.
A detailed medical history was obtained in all study sub-
jects and a full clinical examination was performed. Glyc-
emic control was assessed by measuring of HbA1c (non-
diabetic reference range of 4.1–6.0%), which is reported
to be a reliable indicator of blood glucose level for the last
three months prior to testing [10]. Body weight with sub-
jects in light clothing without shoes and height was meas-
ured and body mass index (BMI) was calculated.
Assessment of depressive symptoms
Depressive symptoms were measured using the 21-item
Beck Depression Inventory (BDI), modified for use in dia-
betic subjects, as described in detail elsewhere [11-13].
Each of the 21 items on the BDI measures the presence
and severity of a symptom of depression by requiring a
self-rating from 0 to 3. A score is determined by summing
the ratings for the individual items [11-13]. The standard
cut-offs are as follows: 0–9 indicates that a person is not
depressed, 10–18 indicates mild-moderate depression,
19–29 indicates moderate-severe depression and 30–63
indicates severe depression [11-13]. According to the
above scales, we considered as a cutt-off point of elevated
depressive symptoms the total score ≥ 19.
The BDI is designed to examine both somatic and cogni-
tive aspects of depression [11-13]. The BDI has been used,
apart from the assessment of the severity of known
depression, for screening purposes. Studies have showed
that BDI is an effective screening test for depression in dia-
betic subjects [12,13].
Statistical Analyses
The following tests were used for the statistical analysis of
the data: the student's t test was used to assess differences
in continuous variables, while the χ2 test was used for cat-
egorical data. Linear regression analysis was used to assess
the relationship between depressive symptoms and the
parameters of metabolic control. P-values < 0.05 were
considered statistically significant.
Results
The demographic characteristics of the study population
are shown in Table 1. Of the study subjects 107 (33.4%)
reported elevated depressive symptoms. Female diabetic
subjects showed more often depressive symptoms than
male diabetic subjects (48.4% vs. 12.7%, P < 0.001) (Fig-
ure 1).
In the female study group, univariate linear regression
analysis showed significant relationships between depres-
sive symptoms and HbA1c (beta = 0.11, P = 0.04), and
duration of diabetes (beta = 0.16, P = 0.004). No signifi-
cant associations were found between depressive symp-
toms and age, BMI, as well as microvascular
complications.
In the male study group, univariate linear regression anal-
ysis showed no significant relationships between depres-
sive symptoms and the testing variables.
Discussion
The present study showed that the prevalence of depres-
sion in a sample of a Greek T2D people was high. The data
regarding the prevalence of depression in T2D subjects in
our country are limited. A previous study reported the fre-
quency of depressive symptoms only in type 1 diabetic
patients [14] and another study in elderly subjects with
diabetes in primary health care [15]. A recent study in a
small sample of elderly diabetic subjects showed no rela-
tionship between diabetes and depression [16].
There is evidence that diabetic people are twice as likely to
have depression compared with nondiabetic persons
[1,17]. Approximately 30% of diabetic subjects have clin-
ically relevant depression [1,17]. However, there are stud-
ies showing conflicting results. A study in newly identified
T2D subjects reported no association between diabetes
and depression [18]. Other studies showed that the risk of
depression in diabetes increases only when comorbid dis-
eases was present [19,20]. In the present study T2D sub-
jects with macrovascular complications were excluded
and therefore the observed prevalence of depression
among T2D subjects is independent of the presence of
comorbid diseases.
The prevalence of depression was significantly higher in
females with diabetes compared with males, confirming
previous results [21-24]. This pattern is similar to report-
ing rates in the general population as well as other medi-
cal conditions [25-27]. It is known that major depression
occurs twice as frequently in women than in men [28] and
seems to be influenced by oestrogen levels [29]. A recentBMC Research Notes 2008, 1:101 http://www.biomedcentral.com/1756-0500/1/101
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study suggested that depressive symptoms are associated
with a modest increase in the risk of T2D in female sub-
jects [30].
In the female study group depressive symptoms were
associated with poor glycemic control and duration of
diabetes, confirming previous reports [21-23]. A meta-
analysis of 28 studies concluded that depression was asso-
ciated with hyperglycemia in patients with T2D [31]. On
the contrary, a study showed an association between
depression and HbA1c levels only in type 1, but not in T2D
patients [24]. Another studies showed that depression
does not influence metabolic control in diabetic people
[32] and that depression appears to be stronger in men
than in women [33].
In this study, we did not find any relationship between
depression and BMI, in contrast to two studies showing
higher BMI in depressed than non depressive diabetic sub-
jects [1,34]. In addition, no relationship was found
between depressive symptoms and microvascular compli-
cations, although previous studies have reported the
opposite [35,36].
Our study has some limitations. Data were collected from
an outpatient diabetic clinic. A possible selection bias
could not be excluded since the more concerned diabetic
patients might seek a specialized diabetes care. Our assess-
ment of depression was based on self-report of symptoms
using a validated instrument, not on the more accurate
clinical diagnostic interview. Furthermore, data on demo-
graphic characteristics of the study subjects were not avail-
able. Studies have showed that depressive symptoms are
higher in diabetic people with lower income as well lower
education level [37]. Finally, diabetic subjects on insulin
therapy and with macrovascular disease were excluded
The depression prevalence in the total sample population and according to gender (Data are shown as %) Figure 1
The depression prevalence in the total sample population and according to gender (Data are shown as %).
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Table 1: Demographic and clinical characteristics of the study 
patients.
Males Females P-value
n (%) 134 (41.9) 186 (58.1) -
Age (years) 62.8 ± 6.8 63.6 ± 7.6 NS
BMI (kg/m2) 28.9 ± 4.9 31.2 ± 5.4 < 0.001
Duration of diabetes (years) 10.5 ± 6.1 12.3 ± 7.2 0.03
HbA1c (%) 7.2 ± 1.3 7.7 ± 1.7 0.001
Retinopathy (yes) n (%) 14 (10.4) 23 (12.4) NS
Neuropathy (yes) n (%) 13 (9.7) 19 (10.2) NS
Nephropathy (yes) n (%) 2 (1.5) 4 (2.2) NS
Depression (yes) n (%) 17 (12.7) 90 (48.4) < 0.001
Data are shown as mean ± SD or as n (%).BMC Research Notes 2008, 1:101 http://www.biomedcentral.com/1756-0500/1/101
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and therefore our results can not be extrapolated to the
diabetic population.
In conclusion, the present study showed that the preva-
lence of depression in Greek T2D subjects without overt
macrovascular complications is comparable to findings
from the recent literature. Diabetic female subjects
showed increased levels of depressive symptoms com-
pared with male subjects. Independent risk factors of
depressive symptoms were diabetes duration and glyc-
emic control.
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